Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
irinotecan (Camptosar) (1 trial)
paclitaxel (taxol) (1 trial)
Stomach Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)